InsiderClue
Stocks · Health care · Wholesale-Drugs, Proprietaries & Druggists' Sundries

DataMeds AI, Inc.

MEDS Clue Score38
United States Fiscal year ends December CIK 0002030763
$2.96 -12.94% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.96 +318.32% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 21 Feb 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Operating income−2.9Net income−2.9EPS, diluted−0.06Fiscal year 2024Revenue18.1Operating income−6.1Net income−6.9EPS, diluted−0.15Fiscal year 2025Revenue23.3 +28.7%Operating income−93.7Net income−101.3EPS, diluted−1.43
FY2023FY2024FY2025
Revenue n/a 18.1 23.3
Growth +28.7%
Operating income −2.9 −6.1 −93.7
Net income −2.9 −6.9 −101.3
Growth
EPS, diluted −0.06 −0.15 −1.43

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2023Fiscal year 2024Gross margin9.7%Operating margin−33.9%Net margin−37.8%Fiscal year 2025Gross margin−27.5%Operating margin−401.7%Net margin−433.9%
FY2023FY2024FY2025
Gross margin n/a 9.7% −27.5%
Operating margin n/a −33.9% −401.7%
Net margin n/a −37.8% −433.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2023Operating cash flow−0.3Fiscal year 2024Operating cash flow−1.2Fiscal year 2025Operating cash flow−10.9
FY2023FY2024FY2025
Operating cash flow −0.3 −1.2 −10.9

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2023Cash0.0Total debt0.4Net cash (debt)−0.3Shareholders’ equity−2.9Fiscal year 2024Cash1.0Total debt22.9Net cash (debt)−21.9Shareholders’ equity6.7Debt to equity3.40Fiscal year 2025Cash0.0Total debt12.6Net cash (debt)−12.6Shareholders’ equity−12.4
FY2023FY2024FY2025
Cash 0.0 1.0 0.0
Total debt 0.4 22.9 12.6
Net cash (debt) −0.3 −21.9 −12.6
Shareholders’ equity −2.9 6.7 −12.4
Debt to equity n/a 3.40 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
n/a 18.1 23.3
Growth +28.7%
n/a 16.4 29.8
n/a 1.8 −6.4
Growth −463.6%
2.9 6.8 70.3
−2.9 −6.1 −93.7
Growth
−2.9 −6.9 −101.3
−2.9 −6.9 −101.3
Growth
Per share
−0.06 −0.15 −1.43
−0.06 −0.15 −1.43
Growth
44.7 47.3 71.0
44.7 47.3 71.0
Growth +5.7% +50.2%

† The diluted share count jumps at 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 3 of 3 years on file.